Masaki Kobayashi

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 23

Top Topics

Surgical Site Infection

Top Venues

Expert opinion on drug safety

Expert opinion on drug metabolism & toxicology

Biopharmaceutics & drug disposition

Xenobiotica; the fate of foreign compounds in biological systems

This page only lists publications with an associated author ORCID identifier.

Publications

Ayako Moriyama, Hinata Ueda, Katsuya Narumi, Shuho Asano, Ayako Furugen, Yoshitaka Saito, Masaki Kobayashi
Contribution of aldehyde oxidase to methotrexate-induced hepatotoxicity: In Vitro and pharmacoepidemiological approaches. Expert opinion on drug metabolism & toxicology (2024)
Taichi Sato, Katsuya Narumi, Rin Taguchi, Komei Ishihara, Hiroshi Satoh, Takao Mori, Keisuke Okamoto, Ayako Furugen, Masaki Kobayashi
Salmon Milt Extract Suppresses Glucose Uptake by Downregulating SGLT1 and GLUT2 Expression in Caco-2 Cells. Biological & pharmaceutical bulletin 47 (9) (2024)
Ayako Moriyama, Hinata Ueda, Katsuya Narumi, Shuho Asano, Ayako Furugen, Yoshitaka Saito, Masaki Kobayashi
Contribution of aldehyde oxidase to methotrexate-induced hepatotoxicity: in vitro and pharmacoepidemiological approaches. Expert opinion on drug metabolism & toxicology 20 (5) (2024)
Taichi Sato, Katsuya Narumi, Rin Taguchi, Komei Ishihara, Hiroshi Satoh, Takao Mori, Keisuke Okamoto, Ayako Furugen, Masaki Kobayashi
Salmon Milt Extract Suppresses Glucose Uptake by Downregulating SGLT1 and GLUT2 Expression in Caco-2 Cells. Biological & pharmaceutical bulletin 47 (9) (2024)
Ayako Moriyama, Hinata Ueda, Katsuya Narumi, Shuho Asano, Ayako Furugen, Yoshitaka Saito, Masaki Kobayashi
Contribution of aldehyde oxidase to methotrexate-induced hepatotoxicity: in vitro and pharmacoepidemiological approaches. Expert opinion on drug metabolism & toxicology 20 (5) (2024)
Ayako Moriyama, Hinata Ueda, Katsuya Narumi, Shuho Asano, Ayako Furugen, Yoshitaka Saito, Masaki Kobayashi
Contribution of aldehyde oxidase to methotrexate-induced hepatotoxicity: In Vitro and pharmacoepidemiological approaches. Expert opinion on drug metabolism & toxicology (2024)
Hinata Ueda, Katsuya Narumi, Shuho Asano, Yoshitaka Saito, Ayako Furugen, Masaki Kobayashi
Comparative study on the occurrence of adverse effects in the concomitant use of azathioprine and aldehyde oxidase inhibitors. Expert opinion on drug safety 23 (1) (2023)
Hinata Ueda, Katsuya Narumi, Shuho Asano, Yoshitaka Saito, Ayako Furugen, Masaki Kobayashi
Comparative study on the occurrence of adverse effects in the concomitant use of azathioprine and aldehyde oxidase inhibitors. Expert opinion on drug safety (2023)
Hinata Ueda, Katsuya Narumi, Shuho Asano, Yoshitaka Saito, Ayako Furugen, Masaki Kobayashi
Comparative study on the occurrence of adverse effects in the concomitant use of azathioprine and aldehyde oxidase inhibitors. Expert opinion on drug safety 23 (1) (2023)
Hinata Ueda, Katsuya Narumi, Shuho Asano, Yoshitaka Saito, Ayako Furugen, Masaki Kobayashi
Comparative study on the occurrence of adverse effects in the concomitant use of azathioprine and aldehyde oxidase inhibitors. Expert opinion on drug safety 23 (1) (2023)
Hinata Ueda, Katsuya Narumi, Shuho Asano, Yoshitaka Saito, Ayako Furugen, Masaki Kobayashi
Comparative study on the occurrence of adverse effects in the concomitant use of azathioprine and aldehyde oxidase inhibitors. Expert opinion on drug safety (2023)
Ayako Furugen, Ayako Nishimura, Takeshi Umazume, Hina Ishikawa, Katsuya Narumi, Masaki Kobayashi
Simple and validated method to quantify lacosamide in human breast milk and plasma using UPLC/MS/MS and its application to estimate drug transfer into breast milk. Journal of pharmaceutical health care and sciences 9 (1) (2023)
Akira Yamagami, Katsuya Narumi, Yoshitaka Saito, Ayako Furugen, Shungo Imai, Yoshimasa Kitagawa, Yoichi Ohiro, Ryo Takagi, Yoh Takekuma, Mitsuru Sugawara, Masaki Kobayashi
Development of a risk prediction model for surgical site infection after lower third molar surgery. Oral diseases (2023)
Hinata Ueda, Katsuya Narumi, Shuho Asano, Yoshitaka Saito, Ayako Furugen, Masaki Kobayashi
Comparative study on the occurrence of adverse effects in the concomitant use of azathioprine and aldehyde oxidase inhibitors. Expert opinion on drug safety 23 (1) (2023)
Genki Yasuda, Atsuhito Kubota, Keisuke Okamoto, Katsuya Narumi, Ayako Furugen, Izumi Kato, Ayako Mori, Yoshitaka Saito, Takashi Satoh, Natsuko Takahashi-Suzuki, Ken Iseki, Masaki Kobayashi
Association between α-defensin 5 and the expression and function of P-glycoprotein in differentiated intestinal Caco-2 cells. Biopharmaceutics & drug disposition (2023)
Mai Koishikawa, Ayako Furugen, Nanami Ohyama, Katsuya Narumi, Shuhei Ishikawa, Masaki Kobayashi
Uptake of antiepileptic drugs in forskolin-induced differentiated BeWo cells: alteration of gabapentin transport. Xenobiotica; the fate of foreign compounds in biological systems 52 (4) (2022)
Yuto Mukai, Atsushi Yamaguchi, Tomoya Sakuma, Takanobu Nadai, Ayako Furugen, Katsuya Narumi, Masaki Kobayashi
Involvement of SLC16A1/MCT1 and SLC16A3/MCT4 in l-lactate transport in the hepatocellular carcinoma cell line. Biopharmaceutics & drug disposition 43 (5) (2022)
Akira Yamagami, Katsuya Narumi, Yoshitaka Saito, Ayako Furugen, Shungo Imai, Yoshimasa Kitagawa, Yoichi Ohiro, Ryo Takagi, Yoh Takekuma, Mitsuru Sugawara, Masaki Kobayashi
Evaluation of the strategies to reduce third-generation oral cephalosporins in dentistry at a Japanese academic hospital: An interrupted time series analysis. Journal of clinical pharmacy and therapeutics 47 (7) (2022)
Yuka Takahashi, Katsuya Narumi, Takanobu Nadai, Hinata Ueda, Taiki Yamamura, Ayako Furugen, Masaki Kobayashi
In vitro and in vivo evaluation of organic anion-transporting polypeptide 2B1-mediated pharmacokinetic interactions by apple polyphenols. Xenobiotica; the fate of foreign compounds in biological systems 51 (11) (2021)
Keisuke Okamoto, Yoshitaka Saito, Hinata Ueda, Katsuya Narumi, Ayako Furugen, Masaki Kobayashi
Kinetic analysis of cystine uptake and inhibition pattern of sulfasalazine in A549 cells. Biopharmaceutics & drug disposition 42 (8) (2021)
Atsushi Yamaguchi, Yoshitaka Saito, Keisuke Okamoto, Katsuya Narumi, Ayako Furugen, Yoh Takekuma, Mitsuru Sugawara, Masaki Kobayashi
Preexisting autoimmune disease is a risk factor for immune-related adverse events: a meta-analysis. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 29 (12) (2021)
Hinata Ueda, Katsuya Narumi, Yu Sato, Ayako Furugen, Masaki Kobayashi, Ken Iseki
Evaluation of possible pharmacokinetic interaction between methotrexate and proton pump inhibitors in rats. Pharmacological reports : PR 72 (5) (2020)
Yuya Futagi, Masaki Kobayashi, Katsuya Narumi, Ayako Furugen, Ken Iseki
Homology modeling and site-directed mutagenesis identify amino acid residues underlying the substrate selection mechanism of human monocarboxylate transporters 1 (hMCT1) and 4 (hMCT4). Cellular and molecular life sciences : CMLS 76 (24) (2019)